[Other] Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab

azadi1987 Post time 1 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-06-27 00:47

Reward20points

journal：JCO Oncology Practice

Authors：Athira Jayan; Jasmine S. Sukumar; Benjamin Fangman; Tejal Patel; Akshara Singareeka Raghavendra; Diane Liu; Sarah Pasyar; Ronald Rauch; Karen Basen-Engquist; Debasish Tripathy; Yinghong Wang; Sonya S. Khan; Carlos H. Barcenas

Published date：2025-9-

DOI：10.1200/op.24.00371

PDF link：https://ascopubs.org/doi/pdfdirect/10.1200/OP.24.00371

Article link：https://doi.org/10.1200/op.24.00371

Article Source：American Society of Clinical Oncology (ASCO)。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report